Fusidic Acid Market Size, Share, Growth, and Industry Growth By Type (Fusidic Acid under 97%, Fusidic Acid 97%-99%, and Fusidic Acid above 99%), By Application (Creams and Ointments, Eyedrops, and Others), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

FUSIDIC ACID MARKET OVERVIEW

The global fusidic acid market, valued at USD 0.22 billion in 2024, is forecasted to increase to USD 0.23 billion in 2025 and surpass USD 0.41 billion by 2033, expanding at a CAGR of 6.7% from 2025 to 2033.

Fusidic acid is an antibiotic medication used to treat bacterial infections. It works by inhibiting the growth and reproduction of bacteria, particularly Staphylococcus aureus and Streptococcus pneumoniae. Fusidic acid is commonly used to treat skin infections, such as impetigo, infected eczema, and infected wounds. It may also be used to treat infections in other parts of the body, such as the respiratory tract, bone, and joints.

Fusidic acid is available in several forms, including tablets, capsules, creams, and eye drops. The medication is generally well-tolerated, but some people may experience side effects such as nausea, vomiting, diarrhea, headache, and skin rash. It is important to take the medication exactly as prescribed and to complete the full course of treatment, even if symptoms improve before the medication is finished.

KEY FINDINGS

COVID-19 IMPACT 

Medical Benefits Boosted Market Demand

The global COVID-19 pandemic has been unprecedented and staggering, with the fusidic acid market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

COVID-19 had a life changing impact globally. The global fusidic acid market share was significantly affected. The virus had various impacts on different markets. Lockdowns were imposed in several nations. This erratic pandemic caused disruptions on all sorts of businesses. Restrictions tightened during the pandemic due to increasing number of cases. Numerous Industries were affected. However, the market for fusidic acid experienced an increased demand.

Some countries may have experienced shortages or delays in the production and distribution of medications, including fusidic acid. Additionally, healthcare resources have been redirected to manage the COVID-19 pandemic, which may have impacted the availability and use of fusidic acid for non-COVID-related bacterial infections.

However with the growing infection rates amidst the pandemic drove the fusidic acid sales. Citizens started preemptive measures to stay cautious of diseases. The role of fusidic acid as a antibiotic medication saw a major surge during the pandemic. However the global fusidic acid market share is anticipated grow following the pandemic.

LATEST TRENDS

Continued R&D to Benefit Market Prospects

One area of research is the use of fusidic acid in combination with other antibiotics to improve treatment outcomes and reduce the development of antibiotic resistance. For example, a 2021 study in the Journal of Antimicrobial Chemotherapy found that adding fusidic acid to a regimen of ceftriaxone and metronidazole improved treatment outcomes for patients with complicated intra-abdominal infections.

Another area of research is the development of new formulations of fusidic acid, such as nanoemulsion and liposomal formulations, which may improve the delivery and effectiveness of the medication. However, ongoing research continues to explore the effectiveness of fusidic acid in treating various bacterial infections. This is anticipated to boost the global fusidic acid market share.

• In 2023, over 37 countries approved fusidic acid-based formulations for dermatological use, reflecting expanding global clinical acceptance.

• More than 21 clinical trials involving fusidic acid combinations were registered globally in 2022, highlighting innovation in bacterial resistance treatment.

Request a Free sample to learn more about this report

FUSIDIC ACID MARKET SEGMENTATION

By Type

Based on type, the market is divided into Fusidic Acid under 97%, Fusidic Acid 97%-99%, and Fusidic Acid above 99%.

By Application

Based on application, the market is bifurcated into Creams and Ointments, Eyedrops, and Others.

DRIVING FACTORS

Effectiveness to Boost Market Share

The driving factor for the use of fusidic acid include its effectiveness against certain types of bacterial infections and its relatively low toxicity and side effects compared to other antibiotics. Fusidic acid is particularly effective against Staphylococcus aureus, including methicillin-resistant strains, and Streptococcus pneumoniae. Fusidic acid is available in several forms, including tablets, capsules, creams, and eye drops, making it a versatile medication for treating various types of bacterial infections.

Antibiotic Resistance to Boost Market Size

Fusidic acid is considered a second-line antibiotic and is often used in combination with other antibiotics to reduce the risk of resistance. Ongoing research is exploring the effectiveness of combining fusidic acid with other antibiotics to improve treatment outcomes and reduce the development of resistance. Hence these factors might boost the growth of the global fusidic acid market share.

• According to a global health database, skin infections affected over 150 million people in Asia-Pacific in 2023, boosting the demand for topical antibiotics like fusidic acid.

• Over 40% of primary care prescriptions for impetigo in Europe in 2022 included fusidic acid, showing sustained clinical reliance.

RESTRAINING FACTORS

Limited Spectrum of Activity to Hamper Market Share

While fusidic acid is effective against certain types of bacteria, it may not be effective against other types of bacteria, such as gram-negative bacteria. Therefore, it may not be the first-line treatment choice for certain bacterial infections. As with all antibiotics, the overuse or inappropriate use of fusidic acid can contribute to the development of antibiotic-resistant bacteria, which can limit the effectiveness of the medication and increase the risk of treatment failure. Hence these factors might impediment the growth of the global fusidic acid market share.

• In 2023, antimicrobial resistance data showed that fusidic acid resistance surpassed 19% in certain bacterial strains, reducing its therapeutic effectiveness.

• Regulatory restrictions in over 9 countries limited over-the-counter sales of fusidic acid, impacting its accessibility for general consumers.

• Request a Free sample to learn more about this report

•  

FUSIDIC ACID MARKET REGIONAL INSIGHTS

Asia-Pacific Dominates the Fusidic Acid Market

APAC is the major shareholder for the global fusidic acid market share. This can be attributed to factors such as the high prevalence of bacterial infections in the Asia Pacific region, particularly in countries, as well as the increasing demand for effective antibiotics in the region. Additionally, the availability of generic versions of fusidic acid in the Asia Pacific region may have contributed to its widespread use. North America is the second major shareholder for global fusidic acid market share.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.

• LEO Pharma: LEO Pharma reported distribution of fusidic acid products in over 90 markets by the end of 2023, with key sales in hospital-grade dermatology solutions.

• Ercros S.A.: Ercros S.A. produced over 110 metric tons of fusidic acid intermediates in 2023 for pharmaceutical-grade synthesis across Europe and Latin America.

List of Top Fusidic Acid Companies

• LEO Pharma [Denmark]
• Ercros [Spain]
• Fuzhou Contay Biotechnology Co.,Ltd [China]
• Joyang Laboratories [China]
• HELM AG [Germany]
• Hoyoo Chemical [China]
• Wellona Pharma [India]

REPORT COVERAGE

This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.